Use of a subcutaneous glucose sensor to detect decreases in glucose concentration prior to observation in blood

The development of a hypoglycemic alarm system using a subcutaneous glucose sensor implies that a decrease in blood glucose is rapidly followed by a decrease in the signal generated by the sensor. In a first set of experiments the linearity and the kinetics of the response of sensors implanted in the subcutaneous tissue of normal rats were investigated during a progressive increase in plasma glucose concentration: the sensitivities determined between 5 and 10 mM and between 10 and 15 mM were not significantly different, and a 5-10 min delay in the sensor's response was observed. In a second set of experiments, performed in diabetic rats, the kinetics of the decrease in subcutaneous glucose concentration following insulin administration was monitored during a decrease in plasma glucose level, from 15 to 3 mmol/L. During the 20 first min following insulin administration, the sensor monitored glucose concentration in subcutaneous tissue with no lag time. Subsequently, the decrease in the estimation of subcutaneous glucose concentration preceded that of plasma glucose. This phenomenon was not observed when the same sensors were investigated in vitro during a similar decrease in glucose concentration and may be due to a mechanism occurring in vivo, such as the effect of insulin on glucose transfer from the interstitial space to the cells surrounding the sensor. It reinforces the interest of the use of implantable glucose sensors as a part of a hypoglycemic alarm.     

Tg/Tm for unsubstituted polymers

Polymers under discussion can be represented by [CH₂)_nR]_p where R is CH₂, CF₂, O, S or CH = CH; and where n can vary from 0 to ∞. The copolymer, P(ethylene-alt-TFE) is also included. These polymers tend to be highly crystalline with resultant confusion about their Tg and hence their Tg/Tm values and a clarification scheme is proposed in which it is considered that each such polymer has a double glass transition, Tg(L)/f(χ_c), Tg(U) = F(χc); and a sub-glass T<Tg(L) at 0.75 Tg(L), where F(χc) signifies a function of fractional crystallinity, χ_c. T<Tg(L) and Tg(L) increase linearly with Tm. The ratio, Tg(L)/Tm, is therefore, not a constant but is close to 0.5. T<Tg(L)/Tg(L) is also not a constant but is close to 0.75. Tg(U) lies within a wedge whose top and bottom sides increase with Tm. The premelting, intracrystalline transition temperature, Tα_c, is also a linear function of Tm. It is suggested that the scheme outlined above should help to resolve uncertainties in assigning transition temperatures for unsubstituted polymers. The low Tg/Tm values for these polymers is discussed in terms of their small da/dc ratios and small crosssectional areas per chain.     

Primary hybrid total hip arthroplasty: an interim followup

The senior authors' initial experience with primary hybrid hip replacement in patients with osteoarthritis was studied to evaluate the efficacy of the procedure. Hybrid total hip arthroplasty (uncemented Harris-Galante acetabular component and cemented Iowa precoated femoral component) was performed in 131 consecutive, nonselected hips in 118 patients with the diagnosis of primary osteoarthritis. Followup was performed at 8 to 9 years after the procedure. The average age at the time of the procedure was 68 years (range, 45-87 years). There were 50 men (55 hips) and 68 women (76 hips). At final followup 19 patients (22 hips) had died. The femoral component had been revised for aseptic loosening in 8 hips (6.1%). One additional hip showed definite radiographic loosening. Hence, the prevalence of radiographic femoral failure was 6.9% (9 hips). No acetabular component had been revised for aseptic loosening and no acetabular component had migrated. The senior author continues to perform hybrid total hip arthroplasty in all patients with primary osteoarthritis. However, design modifications have been made in the femoral component that is used.     

Apolipoprotein(a) concentrations in type 2 (non-insulin dependent) diabetic patients from Romania

Several studies suggested that lipoprotein (a)-Lp(a) is an independent atherogenic risk factor. Since non-insulin-dependent diabetes mellitus (NIDDM) is characterized by an increased risk of coronary heart disease (CHD) as related to the general population, the main purpose of our study was to compare the plasma levels of apolipoprotein (a)-(apo) (a) in 30 NIDDM patients hospitalized in our department, and in 20 non-diabetic controls from Timi?oara. Apo (a) values were similar in the two groups (medians, 95% confidence intervals 57 (50-107) in NIDDM versus 58 (51-106) U/l in controls; p = 0.9097). We found weak correlations between apo (a) and hemoglobin A1 (HbA1) (r = 0.42). A significant association was noticed between apo (a) and apo B, both in NIDDM (r = 0.71) and in control subjects (r = 0.81) p < < 0.001. The diabetic patients were screened for microalbuminaria with the MICRAL-test and we compared apo (a) levels in those having albumin excretion values above and under the cut-off point (20 mg/l). Apo (a) concentrations were similar in both samples. We found no association between apo (a) and plasma lipid values. NIDDM patients on fair glycemic control have similar apo (a) concentrations to non-diabetic subjects and they do not seem to be influenced by diabetes duration, HbA1, microalbuminuria and plasma lipid values Apo (a) and apo B are significantly correlated, both in diabetic and non-diabetic subjects.     

Muon spin relaxation study of amorphous Hf2Co

Muon spin relaxation measurements were carried out in zero magnetic field on amorphous Hf₂Co. The results obtained and comparison with the behaviour of the muon in crystalline Hf₂Co (A. Baudry, P. Boyer, L.P. Ferreira, S.W. Harris, S. Miraglia and L. Pontonnier, J. Phys.: Condens. Matter, 4 (1992) 5025) indicate that muons occupy interstitial sites without Co atoms in first-neighbour positions and diffuse through those sites, suggesting the existence of some degree of short-range order in the amorphous structure. Muon diffusion cannot be described by a single thermally activated process and is faster in the amorphous alloy than in the crystalline alloy.